Genomic sequencing specialist Illumina (NASDAQ: ILMN) was something of a victim in the U.S.-China trade spat on Tuesday.

US President Donald Trump and Chinese leader Xi Jinping are set soon to hold a high-stakes phone call on the tit-for-tat ...

KEY TAKEAWAYSChina retaliated against new U.S. tariffs soon after they took effect Tuesday, imposing duties on the imports of ...

China retaliated to Donald Trump’s opening trade war tariffs by targeting a handful of American companies and slapping levies ...

Authorities also put Calvin Klein owner PVH and US gene sequencing company Illumina onto a so-called blacklist of entities ...

Bosses of big technology firms may find reassurance in comparing artificial intelligence to a lump of coal. Claimed ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

We recently published a list of 35 Non-Tech AI Opportunities Amid DeepSeek Selloff. In this article, we are going to take a look at where Illumina, Inc.

Over the last 20 years, precision medicine has become the standard of care, but for many hospitals, the complexity of the ...

The next leap in AI-driven healthcare requires brain power, a huge investment of money, and the courage to implement.

How an entire institution successfully integrated genomics into everyday careOrginally published on Illumina News Center NORTHAMPTON, MA / ACCESS Newswire / January 28, 2025 / Over the last 20 years, ...

The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, reaching US$ 13.28 ...